Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.

Neurotoxicity Research
Richard M Kostrzewa, Juan Segura-Aguilar

Abstract

Botulinum neurotoxin (BoNT), for more than a hundred years, has been a recognized poisonous principle in spoiled food. As its chemical structure became unraveled, and as more knowledge was gained over its mechanism of toxicity, it became clear that BoNT had the potential to act therapeutically as a targeted toxin that could inactivate specific nerve populations, and thus achieve a therapeutic goal. BoNT has evolved over the past 25 years into a viable therapeutic, now being a first line treatment for dystonia, overtly altering the course of progression of this disorder. BoNT is used for hyperhidrosis and gustatory sweating syndrome, alleviation of pain, as a treatment for overactive bladder, achalasia and anal fissure; and it has gained popularity as a cosmetic aid. Many other possible uses are being explored. The greatest potential for BoNT may lie in its being a molecular Trojan Horse - able to carry a specific enzyme or specific drug to the inside of a cancer or other type of cell while bypassing other cells and thereby having little or no ill effect. BoNT's pharmaceutical potential is boundless.

References

Oct 1, 1996·Diseases of the Colon and Rectum·J S JooS D Wexner
Aug 28, 1998·The Prostate·R DoggweilerR A Schmidt
Dec 14, 2001·Diseases of the Colon and Rectum·Y RonZ Halpern
Jan 17, 2003·Journal of Neurology·Dirk DresslerReiner Benecke
Jul 24, 2003·European Urology·Thomas LeippoldBrigitte Schurch
Dec 17, 2003·International Urogynecology Journal and Pelvic Floor Dysfunction·Dennis DykstraMichael Valley
Mar 18, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Joseph Jankovic
Sep 4, 2004·Journal of Immunological Methods·Scott K DessainRobert A Weinberg
Sep 29, 2004·Diabetes Care·Brian E LacyPankaj J Pasricha
Jan 26, 2005·Neurology·Stephan SchueleEckart Altenmüller
Feb 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Laura CostantinMatteo Caleo
Nov 9, 2005·Neurology·C L ComellaUNKNOWN Dystonia Study Group
Jan 25, 2006·Journal of Molecular Biology·Stefan SikorraThomas Binz
Feb 24, 2006·Biologicals : Journal of the International Association of Biological Standardization·R G A JonesD Sesardic
Mar 10, 2006·Brain Research·Siro LuvisettoFlaminia Pavone
May 30, 2006·Archives of Physical Medicine and Rehabilitation·Catherine C TurkelMitchell F Brin
Jun 21, 2006·Neurotoxicity Research·C TrujilloJ R Murphy
Jun 21, 2006·Neurotoxicity Research·A Fisher, M Montal
Jun 21, 2006·Neurotoxicity Research·G Abbruzzese, A Berardelli
Jun 21, 2006·Neurotoxicity Research·D Dressler, R Eleopra
Jun 21, 2006·Neurotoxicity Research·K A FosterK R Aoki
Jun 21, 2006·Neurotoxicity Research·J Jankovic
Jun 21, 2006·Neurotoxicity Research·H Vittal, P F Pasricha
Jun 21, 2006·Neurotoxicity Research·G BrisindaA Albanese
Jun 21, 2006·Neurotoxicity Research·M L MahowaldD Dykstra
Nov 14, 2006·Journal of the American Academy of Dermatology·Philippa LoweNicholas Lowe
Dec 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Andreas RummelThomas Binz

❮ Previous
Next ❯

Citations

Feb 24, 2009·Analytical and Bioanalytical Chemistry·Fang Wei, Chih-Ming Ho
Mar 1, 2012·Cellular and Molecular Neurobiology·Million Adane TegengeGerd Bicker
Nov 10, 2011·Toxins·Assaf Shapira, Itai Benhar
Oct 14, 2011·Biosensors & Bioelectronics·Fang WeiChih-Ming Ho
Mar 1, 2012·Journal of Cosmetic Dermatology·Timothy Corcoran Flynn
Dec 24, 2009·Journal of Neurochemistry·Tae Gen SonMark P Mattson
Jun 9, 2012·Critical Reviews in Microbiology·Ajay K SinghShashi K Sharma
Mar 1, 2014·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Maurizio CavalliniMassimo Signorini
Oct 28, 2009·Current Opinion in Otolaryngology & Head and Neck Surgery·Jacqui E Allen, Peter C Belafsky
Jan 27, 2009·Current Protocols in Neuroscience·Richard M Kostrzewa
Oct 9, 2019·The Cochrane Database of Systematic Reviews·Francesco C BlumettiJosé A Pinto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.